Skip to main content

Table 1 Characteristics of studies

From: Structural equation modeling the “control of gut overgrowth” in the prevention of ICU-acquired Gram-negative infection

 

Observational studies

Infection prevention studies

 

No intervention

Non-decontamination

Anti-septic

TAP ± PPAP/EAP

Study characteristics

 Sources

Table S1

Table S2

Table S3

Table S4

 Number of studiesa

111

45

13

48

 Origin from systematic reviewb

46

38

7

38

 North American ICUsc

32

10

6

3

 LOS > 7 days

88

37

9

37

 MV for > 48 h for < 90%d

21

1

5

11

 Trauma ICUse

22

8

2

14

 PPAP use in the control groupf

0

0

1

8

 Study publication year (range)

1987–2014

1987–2017

2000–2018

1984–2018

Group characteristics

 Numbers of patients per control group (median; IQR)g

279

135–707

75

61–161

96

36–217

86

31–128

Prevention effect size (odds ratio; 95% CI; number of studies)

 VAP

NA

0.73; 0.66–0.80 (45)

(see Fig S2)

0.89; 0.72–1.11 (10)

(see Fig S3)

0.38; 0.33–0.44 (37)h

(see Fig S4)

 Bacteremia

NA

0.99; 0.71–1.39 (6)

(see Fig S5)

0.72; 0.66–0.79 (10)

(see Fig S6)

0.69; 0.62–0.76 (33)i

(see Fig S7)

  1. aSeveral studies had more than one control and/or intervention group. Hence, the number of groups does not equal the number of studies
  2. bStudies that were sourced from 16 systematic reviews (references in web-only supplementary)
  3. cStudy originating from an ICU in Canada of the USA
  4. dStudies for which less than 90% of patients were reported to receive > 48 h of MV
  5. eTrauma ICU arbitrarily defined as an ICU with more than 50% of admissions for trauma
  6. fUse of PPAP for control group patients. PPAP is protocolized parenteral antibiotic prophylaxis
  7. gData is median and inter-quartile range (IQR)
  8. hVAP prevention effect size for studies not including versus including PPAP in the antibiotic intervention was 0.44; 0.36–0.55 (n = 13) and 0.34; 0.28–0.41 (n = 24), respectively (see Fig S4)
  9. iBacteremia prevention effect size for studies not including versus including PPAP in the antibiotic intervention was 0.77; 0.68–0.88 (n = 10) and 0.57; 0.48–0.67 (n = 22), respectively (see Fig S7)